您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > BIIB068
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
BIIB068
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
BIIB068图片
CAS NO:1798787-27-5
包装与价格:
包装价格(元)
1 mg电议
5 mg电议
10 mg电议
25 mg电议
50 mg电议
100 mg电议
200 mg电议
1 mL*10 mM(in DMSO)电议

产品介绍
BIIB068 是可逆的、选择性的、具有口服活性的BTK抑制剂 (IC50:1 nM;Kd:0.3 nM)。它对BTK的选择性比其他激酶高 400 倍。它可用于自身免疫性疾病的研究。

产品描述

BIIB068 is an selective, reversible and orally active BTK inhibitor (IC50 = 1 nM, Kd = 0.3 nM). BIIB068 is 400 times more selective for BTK than other kinases.

体外活性

BIIB068 inhibits B cell, neutrophil and monocyte activation in vitro, but not T cell responses.

体内活性

BIIB068 demonstrated good PK/PD correlation with in vivo EC50 = 0.16 μM based on antibody esponse, similar to in vivo WB pBTK potency in mice. BIIB068 exhibited no adverse effects in the single dose CNS and respiratory studies in rats nor in a single dose cardiovascular study in monkeys. BIIB068 was well tolerated and effective at inhibiting BTK phosphorylation in healthy subjects.

Cas No.

1798787-27-5

分子式

C23H29N7O2

分子量

435.532

储存和溶解度

DMSO:30mg/ml(68.88mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years